Firefly Neuroscience, Inc.
AIFF
$3.20
-$0.01-0.31%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -10.46M | -7.75M | -4.11M | -3.18M | -2.60M |
| Total Depreciation and Amortization | 12.00K | 8.00K | 4.00K | -- | -- |
| Total Amortization of Deferred Charges | 55.00K | -- | -- | -- | -- |
| Total Other Non-Cash Items | 3.79M | 2.71M | 264.00K | 280.00K | 295.00K |
| Change in Net Operating Assets | 445.00K | -413.00K | 191.00K | -360.00K | 136.00K |
| Cash from Operations | -6.16M | -5.45M | -3.65M | -3.26M | -2.17M |
| Capital Expenditure | -148.00K | -68.00K | -64.00K | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -329.00K | -719.00K | -634.00K | -517.00K | -386.00K |
| Cash from Investing | -477.00K | -787.00K | -698.00K | -517.00K | -386.00K |
| Total Debt Issued | 1.96M | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 4.34M | 7.99M | 4.51M | 4.52M | 4.64M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | 945.00K | 945.00K | 2.22M | 3.16M | 2.36M |
| Repurchase of Preferred Stock | -945.00K | -2.36M | -2.36M | -2.36M | -2.36M |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 6.30M | 6.57M | 4.36M | 5.31M | 4.64M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -333.00K | 337.00K | 11.00K | 1.54M | 2.09M |